Please login to the form below

Not currently logged in
Email:
Password:

The Saatchi & Saatchi Health Award for Launch Excellence

Sponsored by

Finalist

Simponi Launch

MSD


Summary of work

Over 800,000 people in the UK suffer from seriously debilitating auto‐immune diseases of which Rheumatoid Arthritis is one. These conditions can physically disable patients and dramatically impact upon their quality of life.

Anti-Tumour Necrosis Factor (anti‐TNF) drugs have been successfully used over the past 10 years to transform the lives of patients.

The challenge for MSD Immunology was to launch a new anti-TNF Simponi (golimumab) into a highly competitive market where MSD already had an existing anti‐TNF, Remicade (infliximab) still showing double-digit growth 12 years post-launch. 

A co‐positioning strategy was developed for the two brands to be sold alongside each other to present a franchise approach.

A new salesforce structure was put in place to enable Simponi to be launched across three indications, Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis. NICE approval was gained for all licensed indications.

The launch strategy was informed by comprehensive customer insights through a variety of qualitative and quantitative market research across all stakeholder groups (payers, prescribers, patients, and support staff).

Objectives and metrics were set prior to launch which would have to be met if Simponi was to achieve an excellent launch.

By the end of 2011 all launch objectives for Simponi were met or exceeded. Remicade also continued to grow in line with plan.

 

 

Executive summary as submitted


PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

Live webinar:
The power of a good story: Turn your insights into effective storytelling with data visualisation...
clinical research org
The important role of CROs in shaping the future of clinical research across Europe
Looking at the impact of COVID-19 on clinical research activities...
What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...

Infographics